scispace - formally typeset
E

Elizabeth Vincan

Researcher at University of Melbourne

Publications -  65
Citations -  3995

Elizabeth Vincan is an academic researcher from University of Melbourne. The author has contributed to research in topics: Wnt signaling pathway & Frizzled. The author has an hindex of 25, co-authored 52 publications receiving 3522 citations. Previous affiliations of Elizabeth Vincan include Royal Melbourne Hospital & Peter MacCallum Cancer Centre.

Papers
More filters
Journal ArticleDOI

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

TL;DR: Results indicate that ZEB1 triggers an microRNA‐mediated feedforward loop that stabilizes EMT and promotes invasion of cancer cells, and thus explain the strong intratumorous heterogeneity observed in many human cancers.
Journal Article

The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors.

TL;DR: expression of a mutant protein with a 23 amino acid deletion leads to constitutive activation of PI3k providing the first direct evidence that p85alpha is a new oncogene involved in human tumorigenesis.
Journal ArticleDOI

The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression.

TL;DR: The constitutive activation of beta-catenin-dependent Wnt signalling is a necessary initiating event in the genesis of most colorectal cancers as discussed by the authors, and many of the genes associated with tumour invasion and metastasis are transcriptional target genes that are dynamically regulated during cancer progression.
Journal ArticleDOI

Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma.

TL;DR: It is reported that the dominant negative helix-loop-helix regulator Id2 is also a target of the β-catenin/TCF transcription pathway in colon adenocarcinoma and the findings suggest that this dysregulation of Id2 expression is due to the activation of theβ- catenin-TCF pathway.